These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9261261)

  • 1. Modulation of tissue factor protein expression in experimental venous bypass grafts.
    Channon KM; Fulton GJ; Davies MG; Peters KG; Ezekowitz MD; Hagen PO; Annex BH
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1313-9. PubMed ID: 9261261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts.
    Huynh TT; Davies MG; Thompson MA; Ezekowitz MD; Hagen P; Annex BH
    J Vasc Surg; 2001 Feb; 33(2):400-7. PubMed ID: 11174796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts.
    Annex BH; Davies MG; Fulton GJ; Huynh TT; Channon KM; Ezekowitz MD; Hagen PO
    J Surg Res; 1998 Dec; 80(2):164-70. PubMed ID: 9878308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
    West N; Guzik T; Black E; Channon K
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Factor Activity in Dialysis Access Grafts.
    Hasenstab D; Kirkman TR; Clowes AW; Kohler TR
    Ann Vasc Surg; 2016 Feb; 31():179-85. PubMed ID: 26597243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of the regression of intimal hyperplasia in experimental vein grafts.
    Davies MG; Fulton GJ; Svendsen E; Hagen PO
    Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in collagen subtype III and IV protein in experimental venous bypass grafting.
    Fulton GJ; Channon KM; Davies MG; Annex BH; Hagen PO
    Coron Artery Dis; 1998; 9(4):191-7. PubMed ID: 9649925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
    Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
    J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
    Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
    J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.
    Dai L; Gao M; Gu C; Zhang F; Yu Y
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):675-81. PubMed ID: 25838460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
    Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
    Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
    Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
    J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal sequence of G-protein expression in intimal hyperplasia.
    Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
    J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
    Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and function of G-proteins in experimental intimal hyperplasia.
    Davies MG; Ramkumar V; Gettys TW; Hagen PO
    J Clin Invest; 1994 Oct; 94(4):1680-9. PubMed ID: 7929847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
    Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
    J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
    Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
    J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins.
    Ni J; Waldman A; Khachigian LM
    J Biol Chem; 2010 Feb; 285(6):4038-4048. PubMed ID: 19940138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
    el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
    Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramipril and experimental vein graft intimal hyperplasia.
    Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
    Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.